You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 133 No. 5, May 1997 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  STUDIES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Analysis of Tumor-Infiltrating Lymphocytes in Cutaneous Squamous Cell Carcinoma

Andreas C. Haeffner, MD; Karoline Zepter, MD; Craig A. Elmets, MD; Gary S. Wood, MD

Arch Dermatol. 1997;133(5):585-590.


Abstract



Objective
To characterize tumor-infiltrating lymphocytes (TILs) within lesions of cutaneous squamous cell carcinoma (SCC) and related disorders.

Design
Case series with 1- and 2-color immunohistologic, molecular biological analysis of T-cell clonality and in vitro cytotoxicity assays.

Setting
Academic medical center.

Patients
Twenty-one patients, including 6 with actinic keratoses, 4 with SCC in situ, and 11 with invasive SCC.

Results
CD8+ TILs were present within lesions of cutaneous SCC and AK. These cells constituted a variable minority of the total T-cell infiltrate, and many expressed a phenotype consistent with major histocompatibility complex—restricted cytotoxic T lymphocytes: CD3+, TIA1+, CD16-, CD56-, CD57-. They also expressed HLA-DR, suggesting their activation in vivo. Virtually all T cells were T-cell receptor (TCR)-β+{delta}-, indicating that they expressed the TCR-{alpha}β protein heterodimer. Molecular biological analysis of TCR-{gamma} gene rearrangements by the polymerase chain reaction and denaturing gradient gel electrophoresis technique indicated that the TILs were polyclonal. Functional studies suggested that TILs derived from SCC lesions were cytotoxic for autologous tumor cell targets.

Conclusion
Tumor-infiltrating lymphocytes within cutaneous SCC lesions contain a subpopulation of polyclonal, major histocompatibility complex—restricted cytotoxic T lymphocytes expressing the TCR-{alpha}β heterodimer.

Arch Dermatol. 1997;133:585-590



Author Affiliations



From the Departments of Dermatology (Drs Haeffner, Zepter, Elmets, and Wood) and Pathology (Dr Wood), and the Skin Diseases Research Center (Drs Haeffner, Zepter, Elmets, and Wood), Case Western Reserve University, and the Veterans Affairs Medical Center (Dr Wood), Cleveland, Ohio. Dr Haeffner is now affiliated with the Department of Dermatology, University of Zurich, Zurich, Switzerland. Dr Zepter is now with the Department of Dermatology, University of Aachen, Aachen, Germany.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Immunosuppressive Level and Other Risk Factors for Basal Cell Carcinoma and Squamous Cell Carcinoma in Heart Transplant Recipients
Fortina et al.
Arch Dermatol 2004;140:1079-1085.
ABSTRACT | FULL TEXT  

Acitretin for Hypertrophic Lichen Planus-Like Reaction in a Burn Scar
Kossard and Artemi
Arch Dermatol 2000;136:591-594.
FULL TEXT  

Is Favorable Prognosis of Squamous Cell Carcinoma of the Skin Due to Efficient Immune Surveillance?
Smolle and Wolf
Arch Dermatol 1997;133:645-646.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.